title: Expression and function of Fas antigen on activated murine B cells.
abstract: We have studied the expression and function of Fas antigen on murine B lymphocytes. While Fas was present on only a few B cells in the bone marrow, spleen, lymph node or peripheral blood, its expression could be strongly up-regulated by stimulation with soluble CD40 ligand (CD40L). Treatment with anti-IgM and interleukin-4 (IL-4) alone did not induce significant Fas expression but enhanced CD40L-mediated up-regulation of Fas expression. The T cell-derived signal via CD40 is therefore a potent inducer of Fas expression by B lymphocytes. The sensitivity to Fas-mediated apoptosis was found to depend on the duration of B cell activation. B cells activated for 1 day were resistant to Fas-mediated cell death, whereas B cells activated for 3 days were relatively sensitive. Interestingly, different sensitivity to Fas-mediated death signal was observed in 2-day activated B cells. It was found that B cells stimulated with CD40 L alone were more sensitive to Fas-mediated apoptosis than were cells stimulated with CD40L plus anti-IgM or IL-4, and in particular, the combination of the two. The greater sensitivity exhibited by B cells stimulated with CD40L alone seems to be related to limited activation of these cells in the absence of additional stimulation. Co-stimulation of B cells in the presence of CD40L and anti-Fas antibody resulted initially in activation of B lymphocytes, as reflected by the expression of activation markers and cell growth, but this was followed by growth inhibition and cell death. The data demonstrate that the B cell response can be regulated positively and negatively by signaling through CD40 and Fas antigens, respectively.
authors.affiliation: Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: I
authors.initials: I
authors.lastname: Taniuchi
authors.forename: Y
authors.initials: Y
authors.lastname: Maekawa
authors.forename: M
authors.initials: M
authors.lastname: Howard
authors.forename: M D
authors.initials: MD
authors.lastname: Cooper
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism*; D019013:CD40 Antigens / Q000276:immunology / Q000494:pharmacology; D023201:CD40 Ligand; D016923:Cell Death / Q000276:immunology; D006131:Growth Inhibitors / Q000276:immunology / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008562:Membrane Glycoproteins / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D019014:fas Receptor / Q000096:biosynthesis* / Q000276:immunology / Q000494:pharmacology
chemical_list: D000906:Antibodies; D019013:CD40 Antigens; D006131:Growth Inhibitors; D008562:Membrane Glycoproteins; D019014:fas Receptor; D023201:CD40 Ligand